These new anterior of the mouth tongue cancers are NOT from a new strain of HPV since they are testing them for that, and the highly accurate test is finding them negative for HPV period, regardless of sub-typing. The current line of thinking is a genetic commonality in these patients that allows them to be vulnerable to this malignancy, and tomorrow I will pull out the research articles that identify the gene for you. However, this is really not very helpful. What are we going to do, a 600 dollar genetic profile on 300 million (current US population) people to determine who might have the gene? To find perhaps 10,000 people that MAY develop a cancer from it? This is not practical or financially doable, and another approach (if this really is the issue) needs to be found. This is where conventional early detection screening to find the earliest transformations as carcinoma in situ's is very important. AGAIN, the dental and ENT community need to do what is not being done. OPPORTUNISTICALLY screen every patient that walks into their office.


Brian, stage 4 oral cancer survivor. OCF Founder and Director. The first responsibility of a leader is to define reality. The last is to say thank you. In between, the leader is a servant.